Biosense Webster Inc.
Division of Johnson & Johnson
Latest From Biosense Webster Inc.
Starts & Stops: J&J Launches IDE Trial Of 90-Watt RF Ablation Catheter; Vectorious Starts Trial Of V-LAP HF Monitor
Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by MedDeviceTracker. This edition covers trial announcements from Feb. 4 through Feb. 10, including from Johnson & Johnson, Relievant Medsystems, Vectorious, Leviticus, and Kaia Health.
Philips is bulking-up its image-guided therapy portfolio with the acquisition of EPD Solutions, which has a recently CE-marked cardiac imaging and navigation system for ablation procedures to treat heart arrhythmias. EPD was founded by serial inventor and entrepreneur, Shlomo Ben-Haim, the man behind Johnson & Johnson's Biosense Webster business.
HRS 2018 Wrap-Up: Tendril Lead Failures; Metaanalysis Of Contact-Force Catheter; LuxCath's OmniView; More Micra Results
The 2018 Heart Rhythm Society scientific sessions in Boston covered a variety of presentations of new electrophysiology clinical data, including a report on the failure of St. Jude's Tendril leads, a meta-analysis of contact-force catheters for atrial-fibrillation ablation, and new data on Medtronic's Micra leadless pacemaker.
The long-awaited results of the CABANA trial, a large randomized study comparing ablation to drug therapy as a first-line treatment for atrial fibrillation, were presented at the Heart Rhythm Society conference in Boston on May 10. The trial missed its primary endpoint in the "intent to treat" analysis, but showed a significant benefit for ablation in the "as-treated" analysis.
- Diagnostic Imaging Equipment & Supplies
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- Biosense Inc.
- North America
- Parent & Subsidiaries
- Johnson & Johnson
- Senior Management
- Roy Tanaka, Pres.
- Contact Info
Biosense Webster Inc.
Phone: (909) 839-8500
3333 Diamond Canyon Rd.
Diamond Bar, CA 91765
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.